Shire, Takeda, Teva deal

Shire disclosed in its 1Q09 earnings that the company and partner Takeda mutually agreed to terminate a 2008 deal to co-promote Shire's Lialda mesalamine in the U.S. to induce and maintain remission in patients with

Read the full 351 word article

How to gain access

Continue reading with a
two-week free trial.